Medigen, Inc. (Frederick. MD) receives U.S. patent “Vaccines against infectious diseases caused by positive stranded RNA viruses”. This patent will provide freedom of operations to Medigen to develop multiple vaccines based on its proprietary iDNA platform including vaccines for alphaviruses and flaviviruses.
